Efficacy and safety of a combined oral contraceptive containing estradiol valerate/dienogest: Results from a clinical study conducted in North America

Journal of Women's Health

Volumn 23, Issue 3, 2014, Pages 204-210

  Nelson, Anita ^a   Parke, Susanne ^b   Mellinger, Uwe ^b   Zampaglione, Edio ^c   Schmidt, Anja ^c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b Global Clinical Development   (Germany)

^c Bayer Healthcare Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIENOGEST; DIENOGEST PLUS ESTRADIOL VALERATE; ESTRADIOL VALERATE; PLACEBO;

ABDOMINAL PAIN; ACNE; ADULT; AMENORRHEA; ARTICLE; BLEEDING; BREAST DISCOMFORT; BREAST DISEASE; BREAST TENDERNESS; CANADA; CONTRACEPTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSMENORRHEA; FEMALE; HEADACHE; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MASTALGIA; METRORRHAGIA; MIGRAINE; MOOD CHANGE; MOOD SWING; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; MYCOSIS; NAUSEA; NORTH AMERICA; PELVIC PAIN; PILL; PREGNANCY; PRIORITY JOURNAL; SIDE EFFECT; SPOTTING; UNITED STATES; VAGINITIS; VOMITING; WEIGHT GAIN;

ADOLESCENT; ADULT; CANADA; CONTRACEPTION; CONTRACEPTIVES, ORAL, COMBINED; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; FEMALE; HUMANS; MENSTRUAL CYCLE; NANDROLONE; OVULATION INHIBITION; PREGNANCY; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84896113429     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2013.4320     Document Type: Article

References (24)

1. Lindberg UB, Crona N, Stigendal L, Teger-Nilsson AC, Silfverstolpe G. A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters. Thromb Haemost 1989;61:65-69.
2. Astedt B, Svanberg L, Jeppsson S, Liedholm P, Rannevik G. The natural oestrogenic hormone oestradiol as a new component of combined oral contraceptives. Br Med J 1977; 1:269.
3. Kivinen S, Saure A. Efficacy and tolerability of a combined oral contraceptive containing 17beta-estradiol and desogestrel. Eur J Contracept Reprod Health Care 1996;1:183.
4. Koetsawang S, Mandlekar AV, Krishna UR, et al. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception. Contraception 1980;21:445-459.
5. Serup J, Bostofte E, Larsen S, Westergaard J. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation. Acta Obstet Gynecol Scand 1981;60:203-206.
6. Schubert W, Cullberg G. Ovulation inhibition with 17 betaestradiol cyclo-octyl acetate and desogestrel. Acta Obstet Gynecol Scand 1987;66:543-547.
7. Mueck AO, Sitruk-Ware R. Nomegestrol acetate, a novel progestogen for oral contraception. Steroids 2011;76:531-539.
8. Sasagawa S, Shimizu Y, Kami H, et al. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids 2008;73:222-231.
9. Kuhnz W, Blode H, Zimmermann H. Pharmacokinetics of exogenous natural and synthetic estrogens and antiestrogens. In: Oettel M and Schillinger E, eds. Handbook of experimental pharmacology. Berlin: Springer, 1999:261-322.
10. Timmer CJ, Geurts TB. Bioequivalence assessment of three different estradiol formulations in postmenopausal women in an open, randomized, single-dose, 3-way cross-over study. Eur J Drug Metab Pharmacokinet 1999;24:47-53.
11. Dusterberg B, Nishino Y. Pharmacokinetic and pharmacological features of oestradiol valerate. Maturitas 1982;4: 315-324.
12. Oettel M, Bervoas-Martin B, Elger W, et al. A 19-norprogestin without a 17alpha-ethinyl group I: Dienogest from a pharmacokinetic point of view. Drugs Today 1995;31: 499-516.
13. Oettel M, Carol W, Elger W, et al. A 19-norprogestin without 17alpha-ethinyl group II: Dienogest from a pharmacodynamic point of view. Drugs Today 1995;31:517-536.
14. Endrikat J, Parke S, Trummer D, Schmidt W, Duijkers I, Klipping C. Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: Results of two prospective, randomized, open-label studies. Contraception 2008;78:218-225.
15. Palacios S, Wildt L, Parke S, Machlitt A, Romer T, Bitzer J. Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A Phase III trial. Eur J Obstet Gynecol Reprod Biol 2010;149:57-62.
16. Mansour D, Inki P, Gemzell-Danielsson K. Efficacy of contraceptive methods: A review of the literature. Eur J Contracept Reprod Health Care 2010;15:4-16.
17. Astedt B, Jeppsson S, Liedholm P, Rannevik G, Svanberg L. Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17 beta-oestradiol. Br J Obstet Gynaecol 1979;86:732-736.
18. Bayer Oy. Femilar. Available at: http://www.laakeinfo.fi/Medicine.aspx?m = 1968&i = BAYER-FEMILAR (accessed 19 September 2012).
19. Hirvonen E, Allonen H, Anttila M, et al. Oral contraceptive containing natural estradiol for premenopausal women. Maturitas 1995;21:27-32.
20. Westhoff C, Kaunitz AM, Korver T, et al. Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17beta-estradiol: A randomized controlled trial. Obstet Gynecol 2012;119: 989-999.
21. Mansour D, Verhoeven C, Sommer W, et al. Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17beta-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen. Eur J Contracept Reprod Health Care 2011;16:430-443.
22. Akerlund M, Rode A, Westergaard J. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol. Br J Obstet Gynaecol 1993;100:832-838.
23. Archer DF, Jensen JT, Johnson JV, Borisute H, Grubb GS, Constantine GD. Evaluation of a continuous regimen of levonorgestrel/ ethinyl estradiol: Phase 3 study results. Contraception 2006;74:439-445.
24. Ahrendt HJ, Makalova D, Parke S, Mellinger U, Mansour D. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: A seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/ levonorgestrel. Contraception 2009;80:436-444.